Table 2.
Summary of clinical trials of drugs related to CLDN18.2.
| NCT number | stage | Clinical trial | Cancer type | state |
|---|---|---|---|---|
| NCT03816163 | II | IMAB362 + Nab-P + GEM | PCa | Recruitment |
| NCT03159819 | – | CAR-CLD18T | GC and PCa | Recruitment |
| NCT03890198 | I | LCAR-C182Acells | GC and PCa | Recruitment |
| NCT03874897 | I | CAR-TCLDN18.2 | solid tumor | Recruitment |
| NCT04404595 | II | CAR-T (CT041) | GC and PCa | In progress |
| NCT05365581 | – | ASP2138 | G/GEJC and PCa | Recruitment |
| NCT05009966 | – | SYSA1801 | Advanced solid tumor, G/GEJC, and PCa | Recruitment |
Data source: ClinicalTrails.gov.